AstriVax (private company)
See something wrong or missing? Let us know
Offices:Leuven
Industry:
Biotech
Health services
Pharma
Business model:
B2B
AstriVax is a Belgian startup KU Leuven spin-off, developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.
Investors:
we tracked 7 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 30.47m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom